COVID-19 Medication Study for Healthy People

Now Enrolling

Meridian is conducting a clinical trial for an investigational drug for COVID-19. If you are fully vaccinated against COVID-19 and are generally healthy, you may qualify for this study. 

Eligible participants… 

  • Must be age 18 to 65 and healthy  
  • Must have received completed dose(s) in a COVID-19 vaccine series (booster dose(s) allowed but not required) 
  • Must not have a chronic condition that requires continuous use of a prescription or over-the-counter medication 
  • Must have a BMI within the range of 18 to 30 kg/m2 
  • Will receive compensation for study-related time 
  • Do not need insurance to join this study 

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you. 

You can talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Locations


  • Baton Rouge: Meridian Clinical Research, 7912 Summa Ave., Baton Rouge, LA 70809

New York

  • Binghamton: Meridian Clinical Research, 1290 Upper Front Street, Binghamton, NY 13901

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.